12:00 AM
Jul 15, 2013
 |  BC Week In Review  |  Financial News  |  Amended Offerings

Regulus amends follow-on

Regulus Therapeutics Inc. (NASDAQ:RGLS), San Diego, Calif.
Business: Infectious, Cancer, Cardiovascular
Date announced: 7/8/13
Type: Follow-on
To be...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >